- Home
- TARA vs ZVIA Comparison
TARA vs ZVIA Comparison
Compare TARA & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | ZVIA |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.5M | 193.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | TARA | ZVIA |
|---|---|---|
| Price | $5.69 | $1.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $20.40 | $4.89 |
| AVG Volume (30 Days) | 815.8K | ★ 1.2M |
| Earning Date | 11-10-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $162,849,000.00 |
| Revenue This Year | N/A | $7.60 |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.17 |
| 52 Week Low | $2.77 | $1.82 |
| 52 Week High | $7.82 | $4.99 |
Technical Indicators
Market Signals| Indicator | TARA | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 50.75 | 26.31 |
| Support Level | $5.03 | $1.82 |
| Resistance Level | $5.80 | $2.34 |
| Average True Range (ATR) | 0.30 | 0.13 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 67.86 | 11.56 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.